Expressing the fact that the House of Representatives supports the system for prescription drug coverage provided under part D of the Medicare program and believes that changes to such system should not be part of the American Health Care Act of 2017.
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Mar 21, 2017)
Expresses: (1) support for the Medicare prescription drug benefit, and (2) the belief that changes to the benefit should not be included in the American Health Care Act of 2017.
What just happenedMar 24, 2017
Referred to the Subcommittee on Health.
Who’s behind it
- Introduced in HouseMar 21, 2017
- Mar 24, 2017Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Mar 23, 2017Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Mar 21, 2017IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Ways and Means Committee - Mar 21, 2017IntroReferralH11100-A
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Mar 21, 2017IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Energy and Commerce Committee - Mar 21, 2017IntroReferralIntro-H
Introduced in House
- Mar 21, 2017IntroReferral1000
Introduced in House